O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-12.53%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$9.47B
AUM Growth
+$9.47B
(-14%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
41.65%
Holding
145
New
14
Increased
43
Reduced
27
Closed
6
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$95.1M |
| 2 |
Corvus Pharmaceuticals
CRVS
|
$76.2M |
| 3 |
UnitedHealth
UNH
|
$74M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$72.1M |
| 5 |
Eli Lilly
LLY
|
$66.8M |
Top Sells
| 1 |
HNT
HEALTH NET INC
HNT
|
$205M |
| 2 |
Viatris
VTRS
|
$143M |
| 3 |
AFFX
AFFYMETRIX INC
AFFX
|
$75.8M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$56.3M |
| 5 |
Bristol-Myers Squibb
BMY
|
$49.2M |
Sector Composition
| 1 | Healthcare | 90.2% |
| 2 | Financials | 0.22% |
| 3 | Technology | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Insmed
INSM
$28.8B
| $44M | 0.46% |
3,469,900
| – | – |
|
|
DMTX
52
DELISTED
Dimension Therapeutics, Inc
DMTX
| $42.3M | 0.44% |
5,397,698
| – | – |
|
53
Community Health Systems
CYH
$387M
| $40.2M | 0.42% |
2,171,400
-1,210,800
| -36% | -$22.4M |
|
|
BLUE
54
DELISTED
bluebird bio
BLUE
| $40.2M | 0.42% |
945,500
+3,800
| +0.4% | +$162K |
|
55
Acadia Pharmaceuticals
ACAD
$4.38B
| $39.2M | 0.41% |
+1,401,600
| New | +$39.2M |
|
56
Dynavax Technologies
DVAX
$1.19B
| $38M | 0.4% |
1,974,700
-497,500
| -20% | -$9.57M |
|
|
VRAY
57
DELISTED
ViewRay, Inc.
VRAY
| $34.4M | 0.36% |
+7,989,916
| New | +$34.4M |
|
|
ARRY
58
DELISTED
Array Biopharma Inc
ARRY
| $31.5M | 0.33% |
10,689,000
| – | – |
|
59
iShares Biotechnology ETF
IBB
$5.6B
| $29.1M | 0.31% |
+111,700
| New | +$29.1M |
|
|
OTIC
60
DELISTED
Otonomy, Inc.
OTIC
| $27.6M | 0.29% |
1,850,094
| – | – |
|
|
XNPT
61
DELISTED
XENOPORT, INC.
XNPT
| $27.1M | 0.28% |
6,000,400
+232,000
| +4% | +$1.05M |
|
|
MDVN
62
DELISTED
MEDIVATION, INC.
MDVN
| $23M | 0.24% |
501,000
+338,000
| +207% | +$15.5M |
|
63
Stryker
SYK
$150B
| $22.7M | 0.24% |
212,000
+26,000
| +14% | +$2.79M |
|
|
INFI
64
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $19.6M | 0.21% |
3,723,528
-692,772
| -16% | -$3.65M |
|
|
PTLA
65
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $17.1M | 0.18% |
838,100
-463,600
| -36% | -$9.46M |
|
|
SVA
66
DELISTED
Sinovac Biotech, Ltd
SVA
| $17M | 0.18% |
2,667,500
| – | – |
|
|
LUMO
67
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $14.9M | 0.16% |
817,006
-138,300
| -14% | -$2.52M |
|
68
Xencor
XNCR
$580M
| $14.9M | 0.16% |
1,107,022
| – | – |
|
|
AFMD
69
DELISTED
Affimed
AFMD
| $14.7M | 0.15% |
3,931,800
-650,816
| -14% | -$2.43M |
|
70
Standard BioTools
LAB
$481M
| $14.1M | 0.15% |
1,746,100
-703,800
| -29% | -$5.68M |
|
|
PVLA
71
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $13.8M | 0.15% |
7,259,620
| – | – |
|
|
GWPH
72
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $13.8M | 0.14% |
190,600
-113,500
| -37% | -$8.19M |
|
73
Cardinal Health
CAH
$35.5B
| $13.6M | 0.14% |
166,000
+20,000
| +14% | +$1.64M |
|
|
FWP
74
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $13.6M | 0.14% |
798,000
-162,600
| -17% | -$2.76M |
|
|
CYNA
75
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $13.2M | 0.14% |
1,140,325
| – | – |
|